Human TGFalpha-derived Peptide TGFalphaL3 Fused With Superantigen for Immunotherapy of EGFR-expressing Tumours

BMC Biotechnology - United Kingdom
doi 10.1186/1472-6750-10-91
Full Text
Abstract

Available in full text

Categories
Biotechnology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Design of Split Superantigen Fusion Proteins for Cancer Immunotherapy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Induced Pluripotent Stem (iPS) Cell–derived, Chimeric Antigen Receptor (CAR)-expressing T Cells for Immunotherapy

Science-Business eXchange
2013English

Toxoplasma Gondii GRA8-derived Peptide Immunotherapy Improves Tumor Targeting of Colorectal Cancer

Oncotarget
Oncology
2020English

Identification of an Immunogenic DKK1 Long Peptide for Immunotherapy of Human Multiple Myeloma

Haematologica
Hematology
2020English

Human Embryonic Stem Cell (hESC)-derived NK Cells for Cancer Immunotherapy

Science-Business eXchange
2009English

Peptide-Secreting Tumours With Special Reference to the Pancreas.

Gut
Gastroenterology
1969English

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer

Frontiers in Immunology
AllergyImmunology
2018English

P061 Real Clinical Practice of Using Immunotherapy in NSCLC Patients With EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Synthesis of Immunoadjuvant Conjugates With HIV-Derived Peptide Inducing Peptide-Specific Antibody.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy